Chaim Lebovits | CEO |
Eyal Rubin | CFO |
Ralph Kern | CMO & COO |
Jason McCarthy | Maxim Group |
David Bautz | Zacks Investment Research |
Daniel Gryfe | Precise Capital Management |
John Rice | Wells Fargo |
Jason Kolbert | H.C. Wainwright |
John Michael | Private Investor |
Good day and welcome to the BrainStorm Cell Therapeutics' First Quarter 2018 Earnings Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Paul Errant [ph]. Managing Director, Live 5 [ph] Advisors. Please go ahead sir.